Biomarker for predicting likelihood of developing gastric cancer and use thereof
AssigneeSeoul National University Hospital
InventorsSoo Jeong CHO, Sang Gyun KIM, Miree PARK
Life of this patent
Estimating the term…
Loading patent…
AssigneeSeoul National University Hospital
InventorsSoo Jeong CHO, Sang Gyun KIM, Miree PARK
Estimating the term…
Provided are a method for predicting likelihood of developing gastric cancer in a subject, including manufacturing a preparation for measuring the level of mRNA of the genes of CDK1, KDF1, CREB5, and/or AKT2, or the proteins expressed therefrom, measuring with the preparation the level of mRNA of the genes or proteins in a biological sample isolated from the subject, comparing the level of mRNA or protein to that from a control group, and optionally determining that the risk of developing gastric cancer is high when the level of the mRNA or protein in the subject is higher than that from the control group; and a method for predicting prognosis of early gastric cancer patients after treatment by endoscopic submucosal dissection, including the same steps, where the methods have high accuracy and enable the prediction via a one-time measurement by multi-plex PCR with a single tissue sample.
-19. (canceled)
A method for predicting the likelihood of developing gastric cancer, comprising:
A method for predicting the likelihood of developing metachronous gastric cancer, comprising:
A method for predicting the prognosis of early gastric cancer patients after treatment by endoscopic submucosal dissection, comprising:
Dependencies are inferred from the claim text.